Member Sign In

You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate but affiliated companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

This venture remains consistent with the company’s advanced strategic plan to expand its domestic and international footprints. The acquisition has enabled Henry Schein to further expand its business with dental schools in the U.S. and Canada, along with general practice dental offices in Canada.

Henry Schein believes that this acquisition will have no impact on the company's financial results till fiscal 2013. However, the company expects the transaction to be accretive thereafter.

Port Coquitlam, British Columbia-headquartered Exan currently has annual sales of $11.7 million, 75% of which is made up by the company’s dental management software – axiUm. This product has been distributed to 65 dental schools in the U.S. and Canada. The company’s Power Practice software solution is sold to 750 practices in the U.S. and Canada and represents 23% of total revenues.

The firstborn segment of the baby boom generation, initiated in 2011, marked the beginning of an important demographic shift for worldwide dentistry. This trend is expected to gain further momentum over the next 20 years with increasing demand from senior baby boomers. Henry Schein estimates that the population aged 45 or more will grow 14% and 27% within the periods 2011−2021 and 2011−2031, respectively. According to the World Dental Forum held in 2012, this also led to the international integration of the dental industry.

As a result, Henry Schein is currently focusing on global expansion through strategic partnerships and acquisitions. In July, the company made three successive acquisitions namely U.S. based Ortho Technology and Modern Laboratory Services and Thailand based full-service dental distributor Accord. In the same month, it entered into a global distribution agreement with Israel-based dental technology company ReDent Nova. The latest addition of Exan is in pursuance of this strategy.

The company continues to experience strong top-line growth and has established a robust foothold in both domestic and international markets in dental, veterinary and medical supply distribution. We are also encouraged by the company’s focus on improving its cost structure to drive profitability.

Henry Schein’s performance should improve further with the gradual recovery in the economic outlook. However, the company faces stiff competition from the likes of McKesson Corporation (MCK - Analyst Report) and Patterson Companies Inc. (PDCO - Analyst Report). The stock retains a short-term Zacks #3 Rank (Hold).

Top Zacks Features

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

Zacks Research is Reported On:

At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.

Visit performance for information about the performance numbers displayed above.